Remdesivir Efficacy in Coronavirus Disease

Tanta University

Status and phase: Completed; Phase 3; Phase 2

Conditions: COVID

Treatments: Drug: Remdesivir; Other: Standard of care treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT04345419

COVID 19 treatment

Details and patient eligibility

About

COVID 19 treatment using Remedesvir.

Full description

COVID 19 treatment using Remedesvir. Is this drug effective?

Enrollment: 200 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• COVID 19 patients

Exclusion criteria

• allergy or contraindication to the drug

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

200 participants in 2 patient groups, including a placebo group

Remdesivir

Experimental group

Description:

Remdesivir with standard of care treatment standard of care treatment

Treatment:

Drug: Remdesivir

Other: Standard of care treatment

Standard of care

Placebo Comparator group

Description:

Standard of care treatment alone.

Treatment:

Other: Standard of care treatment